表紙:内分泌検査製品市場:製品タイプ別、技術別、検査タイプ別、疾患適応別、エンドユーザー別、地域別:規模、シェア、見通し、機会分析(2022年~2030年)
市場調査レポート
商品コード
1086026

内分泌検査製品市場:製品タイプ別、技術別、検査タイプ別、疾患適応別、エンドユーザー別、地域別:規模、シェア、見通し、機会分析(2022年~2030年)

Endocrine Testing Product Market, by Product Type, by Technology, by Test Type, by Disease Indication, by End User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 208 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
内分泌検査製品市場:製品タイプ別、技術別、検査タイプ別、疾患適応別、エンドユーザー別、地域別:規模、シェア、見通し、機会分析(2022年~2030年)
出版日: 2022年05月15日
発行: Coherent Market Insights
ページ情報: 英文 208 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の内分泌検査製品市場について調査し、市場の概要とともに、製品タイプ別、技術別、検査タイプ別、疾患適応別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査目的・前提条件

第2章 市場概要

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場内訳:製品タイプ別
    • 市場内訳:技術別
    • 市場内訳:検査タイプ別
    • 市場内訳:疾患適応別
    • 市場内訳:エンドユーザー別
    • 市場内訳:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場の機会
  • 影響分析
  • 規制シナリオ
  • PEST分析
  • 最近の製品発売/承認
  • 疫学
  • 合併と買収

第4章 世界の内分泌検査製品市場-COVID-19パンデミックの影響

第5章 世界の内分泌検査製品市場:製品タイプ別、2017年~2030年(100万米ドル)

  • イントロダクション
  • 機器/分析装置
  • 消耗品

第6章 世界の内分泌検査製品市場:技術別、2017年~2030年(100万米ドル)

  • イントロダクション
  • 液体クロマトグラフィ-質量分析
  • イムノアッセイ
  • モノクローナルおよびポリクローナル抗体
  • 電気化学/バイオセンサー(センサー)
  • 臨床化学

第7章 世界の内分泌検査製品市場:検査タイプ別、2017年~2030年(100万米ドル)

  • イントロダクション
  • 副腎皮質刺激ホルモン(ACTH)
  • カルシトニン
  • カルシウム
  • コルチゾール
  • カテコールアミン
  • デヒドロエピアンドロステロン硫酸塩(DHEA-S)
  • エストラジオール
  • 卵胞刺激ホルモン
  • 成長ホルモン
  • 黄体形成ホルモン
  • プロラクチン
  • プロゲステロン
  • テストステロン
  • 甲状腺刺激ホルモン
  • ビタミンD
  • その他

第8章 世界の内分泌検査製品市場:疾患適応別、2017年~2030年(100万米ドル)

  • イントロダクション
  • 副腎不全とアジソン病
  • 骨障害
  • 癌(腫瘍)
  • 不妊
  • 腎疾患
  • 代謝(糖尿病を含む)および胃腸障害
  • 下垂体障害
  • 甲状腺疾患
  • その他

第9章 世界の内分泌検査製品市場:エンドユーザー別、2017年~2030年(100万米ドル)

  • イントロダクション
  • 病院、クリニック
  • 診断研究所
  • サテライト検査室
  • 商業試験所
  • 在宅ケア設備
  • 外来診療センター

第10章 世界の内分泌検査製品市場:地域別、2017年~2030年(100万米ドル)

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第11章 競合情勢

  • 企業プロファイル
    • Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Agilent Technologies
    • BioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthineers
    • Danaher Corporation
    • DiaSorin SpA
    • Immunodiagnostic Systems
    • Laboratory Corporation of America Holdings(LabCorp)
    • Fujirebio, Inc.
    • Thermo Fisher Scientific Inc.
    • Quest Diagnostics
    • Sysmex Corporation
    • MP Biomedicals
    • Ortho Clinical Diagnostics
    • Meridian Life Science, Inc.
  • アナリストの見解

第12章 セクション

目次
Product Code: CMI1755

Endocrine testing includes diagnosis of endocrine related disorders such as infertility, diabetes, and thyroid related disorders. The diagnosis of various endocrine system disorders are determined by evaluating different endocrine hormone levels in the blood. The global endocrine testing market is expected to witness significant growth, owing to increasing incidence of lifestyle disorders such as hypothyroidism, hyperthyroidism, infertility, and diabetes. For instance, according to American Thyroid Association report 2017, the U.S. performs approximately 15% to 30% thyroid fine needle aspiration (FNA) on an annual basis.

Market Dynamics

Market players are engaged in launching new products for endocrine testing products, this is expected to increase the growth of the global endocrine testing products, over the forecast period. For instance, in July 2018, Ortho Clinical Diagnostics launched VITROS XT 7600 Integrated System, at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, held in U.S. It has applications in cardiology, infectious diseases, and endocrinology.

Key players are focusing on inorganic activities such as partnerships, this is expected to increase the growth of the global endocrine testing products market, over the forecast period. For instance, in 2020, Hackensack Meridian Health, an integrated health care network in New Jersey, U.S. and Quest Diagnostics, entered into a partnership, in order to increase the quality and value of diagnostic services provided to patients and their doctors. Under the partnership agreement, Quest Diagnostics will look after all the laboratory operations and also perform reference testing for around 11 Hackensack Meridian Health hospitals under the long-term full laboratory management partnership agreement.

Moreover, in 2016, Sysmex Corporation and Siemens Healthcare Laboratory Diagnostics extended their partnership through the year 2020. Both the companies are indulged in supply, distributorship, and sales and partnership agreement for hemostasis products including analyzers.

Key features of the study:

  • This report provides an in-depth analysis of the global endocrine testing products market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global endocrine testing products market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A., Immunodiagnostic Systems, Laboratory Corporation of America Holdings (LabCorp), Fujirebio, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics, Sysmex Corporation, MP Biomedicals, Ortho Clinical Diagnostics, and Meridian Life Science, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global endocrine testing products market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing products market

Detailed Segmentation:

  • Global Endocrine Testing Products Market, By Product Type:
    • Instruments/Analyzers
    • Consumables
  • Global Endocrine Testing Products Market, By Technology:
    • Liquid Chromatography-Mass Spectrometry
    • Immunoassay
    • Monoclonal and Polyclonal Antibody
    • Electrochemical/Biosensor (Sensor)
    • Clinical Chemistry
  • Global Endocrine Testing Products Market, By Test Type:
    • Adrenocorticotropic Hormone (ACTH)
    • Calcitonin
    • Calcium
    • Cortisol
    • Catecholamine
    • Dehydroepiandrosterone Sulfate (DHEA-S)
    • Estradiol
    • Follicle Stimulating Hormone
    • Growth Hormone
    • Luteinizing Hormone
    • Prolactin
    • Progesterone
    • Testosterone
    • Thyroid Stimulating Hormone
    • Vitamin D
    • Others
  • Global Endocrine Testing Products Market, By Disease Indication:
    • Adrenal Insufficiency and Addison Disease
    • Bone Disorders
    • Cancer (Tumor)
    • Infertility
    • Renal Diseases
    • Metabolic (Including Diabetes) and Gastrointestinal Disorders
    • Pituitary Disorders
    • Thyroid Disease
    • Others
  • Global Endocrine Testing Products Market, By End User:
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Satellite Laboratories
    • Commercial Labs
    • Home Care Settings
    • Ambulatory Care Centers
  • Global Endocrine Testing Products Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Hoffmann-La Roche Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Abbott Laboratories
    • Agilent Technologies
    • BioMerieux S.A.
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthineers
    • Danaher Corporation
    • DiaSorin S.p.A.
    • Immunodiagnostic Systems
    • Laboratory Corporation of America Holdings (LabCorp)
    • Fujirebio, Inc.
    • Thermo Fisher Scientific Inc.
    • Quest Diagnostics
    • Sysmex Corporation
    • MP Biomedicals
    • Ortho Clinical Diagnostics
    • Meridian Life Science, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Technology
    • Market Snippet, By Test Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Recent Product Launch/Approval
  • Epidemiology
  • Mergers and Acquisitions

4. Global Endocrine Testing Products Market - Impact of Coronavirus (Covid-19) Pandemic

  • Impact on Supply Chain
  • Impact on Research and Development
  • Government Initiatives

5. Global Endocrine Testing Products Market, By Product Type, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Instruments/Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Endocrine Testing Products Market, By Technology, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Liquid Chromatography-Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Immunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Monoclonal and Polyclonal Antibody
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Electrochemical/Biosensor (Sensor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Clinical Chemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Endocrine Testing Products Market, By Test Type, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Adrenocorticotropic Hormone (ACTH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Calcitonin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Calcium
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Cortisol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Catecholamine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Dehydroepiandrosterone Sulfate (DHEA-S)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Estradiol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Follicle Stimulating Hormone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Growth Hormone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Luteinizing Hormone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Prolactin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Progesterone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Testosterone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Thyroid Stimulating Hormone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Vitamin D
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Endocrine Testing Products Market, By Disease Indication, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Adrenal Insufficiency and Addison Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Bone Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Cancer (Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Infertility
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Renal Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Metabolic (Including Diabetes) and Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Pituitary Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Thyroid Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

9. Global Endocrine Testing Products Market, By End User, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Satellite Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Commercial Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

10. Global Endocrine Testing Products Market, By Region, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

11. Competitive Landscape

  • Company Profiles
    • Hoffmann-La Roche Ltd.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Abbott Laboratories
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Agilent Technologies
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • BioMerieux S.A.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Bio-Rad Laboratories, Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Siemens Healthineers
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Danaher Corporation
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • DiaSorin S.p.A.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Immunodiagnostic Systems
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Laboratory Corporation of America Holdings (LabCorp)
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Fujirebio, Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Thermo Fisher Scientific Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Quest Diagnostics
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Sysmex Corporation
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • MP Biomedicals
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Ortho Clinical Diagnostics
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Meridian Life Science, Inc.
  • Company Overview
  • Drug Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

12. Section

  • References
  • Research Methodology
  • About us and Sales Contact